Breakthrough drug TRG-035 enters human trials to regrow teeth naturally

Breakthrough drug TRG-035 aims to regrow human teeth naturally by targeting USAG-1 protein, offering hope for millions with tooth loss.

Illustration of tooth regrowth concept showing healthy teeth and roots, representing TRG-035 drug research.
Caption: Scientists launch human trials of TRG-035, a breakthrough drug designed to regrow human teeth naturally. (Image courtesy of Boka)

Breakthrough drug TRG-035 enters human trials to regrow teeth naturally

A revolutionary breakthrough in dental medicine is underway in Japan, where researchers have launched the first human clinical trials of TRG-035, a drug designed to regrow human teeth naturally. This pioneering treatment could transform oral healthcare for millions of people worldwide who suffer from tooth loss.

How TRG-035 works

TRG-035 functions by targeting and inhibiting USAG-1, a protein that naturally suppresses tooth growth. By blocking USAG-1, the drug reactivates dormant biological pathways, enabling the body to regenerate lost teeth — a process previously thought to be impossible in humans.

Promising results in animal studies

Earlier experiments in mice and ferrets demonstrated remarkable success, with animals growing entirely new teeth after receiving TRG-035. These results gave researchers the confidence to proceed with human testing, marking a historic milestone in regenerative dentistry.

Potential impact

If proven safe and effective, TRG-035 could replace conventional treatments like dentures, dental implants, and bridges, offering patients the chance to regrow their own natural teeth. Experts believe the therapy could be especially beneficial for:

  • Adults with multiple missing teeth from decay or trauma
  • Patients with congenital conditions such as tooth agenesis
  • Elderly individuals struggling with tooth loss and oral health decline

Expert insights

Dr. Katsu Takahashi, head of the research team at Kyoto University, highlighted the groundbreaking potential of the therapy:

“For decades, dentistry has relied on artificial replacements. With TRG-035, we are taking a step toward restoring what nature gave us — real, living teeth.”

Looking ahead

The clinical trial phase is expected to continue through 2025. If results confirm the drug’s safety and effectiveness, TRG-035 could be available for broader medical use later this decade, ushering in a new era of natural tooth regeneration.

Stay informed. Stay ahead.

CLICK HERE TO FOLLOW Dental News Pakistan WhatsApp Channel for trusted healthcare updates, expert insights, clinical research, policy news, and dental breakthroughs—delivered directly to you.

Submit Blog